Nachrichten zur ACADIA Pharmaceuticals Aktie

What Makes Acadia Pharmaceuticals (ACAD) a Strong Momentum Stock: Buy Now-

Does Acadia Pharmaceuticals (ACAD) have what it takes to be a top stock pick for momentum investors? Lets find out....…

Is Acadia Pharmaceuticals Stock Now a Buy-

Acadias shares shrugged off a stronger-than-expected Q3 earnings report yesterday....…

ACADIA Pharmaceuticals initiates phase 3 pivotal study of trofinetide in Rett Syndrome

Rett syndrome is a serious and rare neurodevelopmental congenital CNS disorder with symptoms that typically present between six to 18…

Acadia Pharmaceuticals Delivers Record Q3 Revenue, Fueled by Antipsychotic Drug Nuplazid

The biotech continues to enjoy great momentum for its only approved drug, with a big new FDA approval potentially on…

Acadia Pharmaceuticals (ACAD) Q3 2019 Earnings Call Transcript

ACAD earnings call for the period ending September 30, 2019....…

ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q3 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA Pharmaceuticals Inc. 2019 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of 29.27% and 6.79%, respectively, for the quarter ended September 2019. Do the…

Heres Why Acadia Pharmaceuticals Jumped 30.1% in September

Unexpected phase 3 clinical trial data has investors smiling....…

ACADIA Pharmaceuticals, Inc. (ACAD) Management Presents at 2019 Cantor Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharma Jumps on Positive Data From Depression Treatment Candidate

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA pharmaceuticals prices equity offering at $40; shares down 3% premarket

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Upgrades and Downgrades: Acadia Pharma, Broadcom, CBOE, Etsy, Gap, GE, Home Depot, Lowes, Oracle, Slack and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ford, Domo, Acadia Pharmaceuticals: Mad Money Lightning Round

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Does Acadia Pharmaceuticals Have More Room to Run-

Acadias stock has taken flight this year....…

ACADIA Surges on Early Success of Nuplazid Dementia Study

ACADIA Pharmaceuticals (ACAD) Parkinsons psychosis drug, Nuplazid, meets primary endpoint earlier than expected in late-stage label expansion study evaluating it…

Acadia Pharmaceuticals upgraded to buy at Canaccord Genuity

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Acadia Pharmaceuticals a Good Biotech Stock to Buy Now-

Lackluster sales of Nuplazid could finally take flight next year....…

Why Acadia Pharmaceuticals Stock Skyrocketed Today

Acadias flagship drug notched a key late-stage win today....…

Mid-Afternoon Market Update: NASADQ Down 0.5%; ACADIA Pharmaceuticals Shares Spike Higher

Toward the end of trading Monday, the Dow traded up 0.05% to 26810.56 while the NASDAQ fell 0.52% to 8060.73.…

Acadia Stops Nuplazid Study Early After Drug Shows Statistically Superior Efficacy In Dementia-Related Psychosis

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares are soaring to their highest level in about two years following a clinical trial…

Acadia Pharmaceuticals Surges on Positive Trial Results for Psychosis Treatment

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA Enters Oversold Territory

ACADIA Pharmaceuticals has been on a bit of a cold streak lately, but there might be light at the end…

Thinking about buying stock in Acadia Pharmaceuticals, Aurora Cannabis, Bank of America, SINTX Technologies, or AT&T-

NEW YORK , Sept. 9, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACAD,…

Acadia Pharma up 68% premarket on positive pimavanserin data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals stock rockets after late-stage trial of pimavanserin mets primary endpoint

Shares of Acadia Pharmaceuticals Inc. rocketed 87% toward a 4-year high in premarket trading Monday, after the biopharmaceutical company…

ACADIA Pharmaceuticals Inc. (ACAD) Shares March Higher, Can It Continue-

As of late, it has definitely been a great time to be an investor in ACADIA Pharmaceuticals Inc. (ACAD)....…

Why Acadia Pharmaceuticals Stock Is Crushing It Today

Great Q2 results powered by strong momentum for antipsychotic drug Nuplazid have investors fired up....…

Acadia Pharmaceuticals Beats Expectations in Q2

Nuplazid picked up momentum in the second quarter, enabling Acadia to up its full-year 2019 outlook....…

Acadia Pharmaceuticals (ACAD) Q2 2019 Earnings Call Transcript

ACAD earnings call for the period ending June 30, 2019....…

ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q2 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Tops Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of 17.39% and 13.86%, respectively, for the quarter ended June 2019. Do the…

ACADIA Pharmaceuticals Inc. 2019 Q2 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Acadia Pharmas Schizophrenia Treatment Done For-

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Acadia Pharmaceuticals Is Tanking Today

Shares slump after the drugmaker releases bummer clinical news....…

Acadia stock drops as schizophrenia drug doesnt pass clinical trial

Acadia Pharmaceuticals Inc. shares dropped in the extended session Monday after the biotech drug maker said its schizophrenia treatment…

Acadias schizophrenia treatment fails to meet main goal of late-stage study

Acadia Pharmaceuticals Inc said on Monday its add-on treatment for schizophrenia failed to meet the main goal in a late-stage study....…

Why Acadia Pharmaceuticals Stock Slumped in April

The contentious drug-pricing debate weighed on Acadia Pharmaceuticals shares last month....…

ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals (ACAD) Q1 2019 Earnings Call Transcript

ACAD earnings call for the period ending March 31, 2019....…

Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Tops Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of -9.26% and 6.17%, respectively, for the quarter ended March 2019. Do the…

Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for

Acadia (ACAD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Why Acadia Pharmaceuticals Stock Perked Up in February

The companys comeback story continued to gain momentum last month....…

ACADIA Pharmaceuticals, Inc. (ACAD) Presents at 8th Annual SVB Leerink Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ACADIA Pharmaceuticals Inc. 2019 Q4 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals Inc (ACAD) Q4 2018 Earnings Conference Call Transcript

ACAD earnings call for the period ending December 31, 2018....…

ACADIA Pharmaceuticals, Inc. (ACAD) CEO Stephen Davis on Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Smartest People on Wall Street Are Buying These 3 Stocks -- Should You-

Acadia Pharmaceuticals, Vanguard FTSE Emerging Markets, and Kraft Heinz are attracting Wall Streets best....…

Will ACADIA Pharmaceuticals Continue to Surge Higher-

As of late, it has definitely been a great time to be an investor in ACADIA Pharmaceuticals Inc....…

ACADIA Pharmaceuticals Inc. (ACAD) at JPMorgan Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…